Acrigen Biosciences, Inc. — National Science Foundation SBIR Phase I: BM
Acrigen Biosciences, Inc. — SBIR Phase I award from National Science Foundation.
- Amount
- $225,000
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- BM
- NAICS
- —
- Place of performance
- CA
- Period
- 2020-08-15 → 2021-01-31
Description
The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to enable safe and effective human gene editing, providing therapies targeting myriad human genetic diseases. CRISPR (clustered, regularly interspaced, short palindrom